DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnemonic : ALOPM) (Paris:ALOPM), a biopharmaceutical company specializing in precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback